Skip to content

American Healthcare REIT

US · AHR #1336 by market cap Listed 2024
57.54 -0.07 -0.12%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

Valuation each multiple against its own 5-year range

P/B ratio 2.41 In line with history 46th percentile
5-year average 2.35 · #12 of 17 in REIT - Healthcare Facilities
P/E ratio 117.43 Expensive vs history 84th percentile
5-year average -9.65 · forward 62.80 · #13 of 14 in REIT - Healthcare Facilities
P/S ratio 5.00 Expensive vs history 95th percentile
5-year average 2.85 · forward 3.94 · #8 of 17 in REIT - Healthcare Facilities

Vs. peers REIT - Healthcare Facilities

Company Market cap P/E (TTM) P/B Div yield
American Healthcare REIT (AHR) 13.35B 117.43 2.41 1.74%
Welltower (WELL) 176.32B 104.95 3.63 1.28%
Healthpeak Properties (DOC) 13.27B 35.63 1.69 6.34%
National Healthcare Properties (NHP) 1.08B -45.18 1.18 0.51%
Medical Properties Trust (MPT) 1.03B 4.17 0.22 20.57%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value55.40 Economic moatNarrow UncertaintyMedium

Trading 3.7% above Morningstar's fair value estimate.

Fair value

American Healthcare REIT Inc receives a 3-star quantitative star rating, reflecting our opinion that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 4% premium over our quantitative fair value estimate of $55.40 per share; however, this estimate should be taken with a pinch of salt due to its medium uncertainty rating.

The firm's lack of profitability decreases our estimated fair value. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. For example, the firm's earnings yield of 1.2% sits in the bottom 40% compared with global peers. The earnings generated by the company relative to its share price is concerning, which contributes to our view that shares are overvalued.

The company's valuation metrics are an additional cause for concern. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's enterprise value to market value ratio of 1.1, a core component of valuation, sits in the top 45% compared with global peers. The market value of equity is low relative to the business' enterprise value, suggesting the company could be buried in debt if anything goes wrong. This characteristic further promotes our unfavorable price/fair value ratio.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. This outperformance may signify a bull trap, in light of other detractors from our model.

Economic moat

The narrow moat rating for this company indicates investors can expect it to generate 10 years or more of excess returns on capital due to its respectable competitive advantages. Its moat is bolstered by its strong financial health, which indicates low near-term bankruptcy risk.

By Quantitative Equity Report

Quote time 2026-11-20 20:01:32 · For reference only, not investment advice and not tailored to your situation.

American Healthcare REIT discussion 0 comments

Add a comment